Navigation Links
Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information
Date:10/17/2007

Landmark Meeting Dec. 6, 2007 to Address FDA's Next Big Challenge

WASHINGTON, Oct. 17 /PRNewswire-USNewswire/ -- Is the Food and Drug Administration effectively communicating risk/safety information on drugs and devices to physicians and the public?

That's a key question a panel of experts will discuss and debate at a landmark Colloquium, Communicating Risk/Safety Information: How FDA Is Meeting the Challenge, sponsored by the Food and Drug Law Institute (FDLI), Dec. 6, 2007, in Washington, D.C.

This meeting is the third in a series of colloquia sponsored by FDLI. Under its new strategic direction, FDLI is committed to using the Colloquium series as a neutral forum to address the legal, regulatory, policy and practical implications of technological innovations affecting the food and drug industry.

As the public becomes more concerned about whether it's safe to take -- or stop -- their medications, FDA is making risk communication a top priority. The agency is forming an advisory committee on communication and implementing new Congressional requirements on risk evaluation. But it's unclear what that means for those who must deal with adverse events and contraindications every day.

Colloquium attendees will receive:

> Results of a study on how FDA handled the antidepressant drug controversy;

> Analysis of the new risk evaluation and mitigation strategy (REMS) requirements;

> Tips on developing world-class risk/safety and communications plans;

> Vital information on FDA's new Risk Communications Advisory Committee;

> An inside look at FDA's overall from communications strategy from its Deputy Commissioner and Chief Medical Officer Janet Woodcock, M.D.; and

> Excerpts from FDA's Response to the IOM's Report on Drug Safety.

The expert panel includes:

> Janet Woodcock, Deputy Commissioner & Chief Medical Officer, FDA;

> Randall W, Lutter, Deputy Commissioner for Policy & Planning, FDA;

> Stuart M. Pape, Managing Partner, Patton Boggs;

> Robert Dormer, Partner, Hyman Phelps & McNamara;

> Grace-Marie Turner, President, Galen Institute;

> Susan Newberry, Senior Vice President, Director, D.C Healthcare Practice,

Ketchum Communications; and

> Kelly Posner, Associate Professor, Columbia University.

Registration is $295 for FDLI members, $395 for non-members. Attendance is limited, so registrants are strongly urged to sign up early.

To register, visit http://fdli.org or call (800) 956-6923 or (202) 371-1420.

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field.


'/>"/>
SOURCE Food & Drug Law Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Hundred million dollar gift for malaria institute
2. Magsaysay Award for Dr.Shanta from Chennai Cancer Institute
3. Ontario Institute for Cancer Research is funded $142 million
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
6. Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function
7. Georgia Institute of Technology develops doppler Vein finder
8. Germany Institutes Tough Measures To Tackle Bird Flu
9. MoH Considering Hiking Fees, Private Institutes Are Worried
10. Business model for Liver Institute cleared by Delhi Cabinet
11. Government to Open More Pharma Institutes Across India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology: